Next Article in Journal
Biomarkers as Prognostic Predictors and Therapeutic Guide in Critically Ill Patients: Clinical Evidence
Previous Article in Journal
An Overview of Specific Considerations in Chronic Venous Disease and Iliofemoral Venous Stenting
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
JPM
Volume 13
Issue 2
10.3390/jpm13020332
jpm-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Case Report

Successful Ultrasound-Guided Methotrexate Intervention in the Treatment of Heterotopic Interstitial Pregnancy: A Case Report and Literature Review

by
Ping Li
1,2,†,
Xiao Tan
1,3,†,
Yi Chen
1,
Qiaoli Ge
1,
Haiying Zhou
1,
Renrong Zhang
1,3,
Yue Wang
1,
Min Xue
1,
Ruifang Wu
4,5,* and
Desheng Sun
1,*
1
Department of Ultrasonography, Peking University Shenzhen Hospital, Shenzhen 518036, China
2
Department of Ultrasonography, Weifang People’s Hospital, Weifang 261044, China
3
Department of Zhuhai Campus, Zunyi Medical University, Zunyi 563006, China
4
Center of Obstetrics and Gynecology, Peking University Shenzhen Hospital, Shenzhen 518036, China
5
Institute of Obstetrics and Gynecology, Shenzhen PKU-HKUST Medical Center, Shenzhen 518036, China
*
Authors to whom correspondence should be addressed.
†
These authors contributed equally to this work.
J. Pers. Med. 2023, 13(2), 332; https://doi.org/10.3390/jpm13020332
Submission received: 10 January 2023 / Revised: 31 January 2023 / Accepted: 8 February 2023 / Published: 15 February 2023
(This article belongs to the Section Methodology, Drug and Device Discovery)
Browse Figures
Review Reports Versions Notes

Abstract

:
Purpose: This study aims to share the experience of minimally invasive ultrasound-guided methotrexate intervention in the treatment of heterotopic interstitial pregnancy (HIP) with good pregnancy outcomes, and to review the treatment, pregnancy outcomes, and impact on the future fertility of HIP patients. Methods: The paper describes the medical history, clinical manifestations, treatment history, and clinical prognosis of a 31-year-old woman with HIP, and reviews cases of HIP from 1992 to 2021 published in the PubMed database. Results: The patient was diagnosed with HIP by transvaginal ultrasound (TVUS) at 8 weeks after assisted reproductive technology. The interstitial gestational sac was inactivated by ultrasound-guided methotrexate injection. The intrauterine pregnancy was successfully delivered at 38 weeks of gestation. Twenty-five HIP cases in 24 studies published on PubMed from 1992 to 2021 were reviewed. Combined with our case, there were 26 cases in total. According to these studies, 84.6% (22/26) of these cases were conceived by in vitro fertilization embryo transfer, 57.7% (15/26) had tubal disorders, and 23.1% (6/26) had a history of ectopic pregnancy; 53.8% (14/26) of the patients presented with abdominal pain and 19.2% (5/26) had vaginal bleeding. All cases were confirmed by TVUS. In total, 76.9% (20/26) of intrauterine pregnancies had a good prognosis (surgery vs. ultrasound interventional therapy 1:1). All fetuses were born without abnormalities. Conclusions: The diagnosis and treatment of HIP remain challenging. Diagnosis mainly relies on TVUS. Interventional ultrasound therapy and surgery are equally safe and effective. Early treatment of concomitant heterotopic pregnancy is associated with high survival of the intrauterine pregnancy.

1. Background

Interstitial pregnancy (IP) is a rare ectopic pregnancy (EP), accounting for 2–4% of tubal EP [1]. The gestational sac is implanted into the interstitial part of the fallopian tube, and the surrounding blood supply is rich. Once ruptured, fatal bleeding may occur [2]. The maternal mortality rate is as high as 2.5%, which is seven times that of other types of tubal EP [3]. The coexistence of an IP and an intrauterine pregnancy (IUP) is called a heterotopic interstitial pregnancy (HIP), which is the most life-threatening type of EP. During natural conception, the incidence of HIP is very low [4]. In recent years, with the increase in infertility and the development of assisted reproductive technology (ART), the incidence of HIP has greatly increased [5]. The existence of IUP also increases the complexity of HIP diagnosis and treatment. Thus, attention must be paid to the following issues: the desire of the expectant parents for the health of the baby in utero and the protection of future fertility, and the threat to the life of the mother and intrauterine fetus by ectopic gestational sac rupture.
However, there is currently no unified treatment standard for HIP. We share a case of ultrasound-guided methotrexate intervention for HIP and review the literature on the treatment. Written consent for this case has been obtained and kept in the medical record.

2. Case Description

A 31-year-old woman came to Peking University Shenzhen Hospital complaining of slight vaginal bleeding and tenesmus for 8 h. She had undergone in vitro fertilization (IVF) and transferred two frozen embryos into the uterine cavity at the hospital 38 days prior. On the 14th day after embryo transfer (ET), she routinely received a serum β-human chorionic gonadotropin (β-hCG) test, which showed 2372 IU/L, indicating pregnancy. On day 30 after ET, the patient had her first ultrasound, which revealed an embryo in the uterus. During this period, the patient and the embryo were in a stable condition. However, on the 38th day after ET, she had a small amount of vaginal bleeding and tenesmus, so she returned to the hospital for treatment. Two gestational sacs were unexpectedly discovered by transvaginal ultrasonography (TVUS) on day 38 after ET: one was in the uterine cavity with a fetal bud of 15 mm long and with a fetal heartbeat, and the other was located in the right interstitial part of the fallopian tube, which was not communicated with the uterine cavity. In this gestational sac mass, there was a fetal bud about 5 mm long, and the fetal heart rate was not yet obvious, but the blood flow signal around the mass was abundant (Figure 1). In addition, the patient’s serum β-hCG level was shown to be higher than 264,000 IU/L. She was finally diagnosed with HIP based on TVUS, serum β-hCG levels, and multidisciplinary expert consultation.
Given that this IP was still growing, it was necessary to promptly inactivate the EP. Two treatment options were presented to the patient: laparoscopic surgery or fetal reduction treatment. Ultimately, the patient and her partner gave written consent for the patient to undergo the ultrasound-guided local injection of methotrexate (MTX) to inactivate the interstitial gestational sac after fully understanding the possible risks to the mother and fetus. For the procedure, the patient lay in the supine position with her lower abdomen fully exposed. The puncture point was chosen, and the drape was then routinely disinfected. Under the real-time guidance of ultrasound, an 18G puncture needle was advanced to the villus implantation site of the right IP, after which 20 mg of MTX (0.4–0.5 mg/kg body weight was dissolved in 5 mL of normal saline) was slowly injected into the interstitial gestational sac [6]. The needle was then pulled out after inserting the needle core. The process went smoothly. Subsequent serial ultrasound scans and serum β-hCG level tests were performed to dynamically observe the changes in the EP and IUP. On the second day after injection, the interstitial gestational sac measured about 32 × 22 mm, and there was a slight streak-like blood flow signal around it. On the 7th day, there was no significant change in the ectopic gestational sac, and the serum β-hCG level was 235,123 IU/L. On the 14th day, the ectopic gestational sac was larger, about 44 × 43 mm in size, with abundant peripheral blood vessels (Figure 2). On the 18th day, the ectopic gestational sac had grown to its largest size, about 58 × 40 mm. After this, it became increasingly smaller until the 22nd week of gestation, when it was about 35 × 30 mm in size and surrounded by fewer blood vessels. On the 20th day, the serum β-hCG level of the patient was 85,702 IU/L. The changes in the size of the interstitial gestational sac and the serum β-hCG level are respectively presented in Figure 3A,B.
The patient had regularly been undergoing prenatal examination in the hospital until the 22nd week of gestation. After that, she visited another hospital, and was followed up with via telephone. The IUP evolved normally and uneventfully. The patient gave birth to a boy with patent ductus arteriosus (PDA) in another hospital at 38 weeks of pregnancy. The interstitial gestational sac finally disappeared on the 51st day after delivery.

3. Literature Review

Materials and Methods

The search terms “heterotopic interstitial pregnancy [all fields]”, “((interstitial pregnancy) AND heterotopic pregnancy [all fields])”, or “interstitial pregnancy complicated with intrauterine pregnancy [all fields]” were used to search studies published on the PubMed database in English from 1992 to 2021, including references and review articles of relevant case reports. Additionally, reports of angular heterotopic pregnancy were excluded.
All case reports of HIP were selected, regardless of the treatment or outcome, and reported data on clinical manifestations, risk factors, treatments, and outcomes were registered. Some reports did not contain all of these data.

4. Result

Based on the search strategy described previously, 120 relevant English documents published on PubMed were retrieved. After reading the full text, 24 articles with 25 cases (Table 1) were finally selected. Including the present case, a total of 26 cases were included.
It was found that patients in 84.6% (22/26) of these cases had conceived through in vitro fertilization embryo transfer (IVF-ET). Moreover, 57.7% (15/26) of the patients in these cases had fallopian tube disorders, and 23.1% (6/26) had a history of EP.
Regarding clinical manifestations, 53.8% (14/26) of the patients in these cases complained of abdominal pain, 19.2% (5/26) had symptoms of vaginal bleeding, and 26.9% (7/26) had no clinical symptoms. All cases were confirmed by TVUS. In these cases, the earliest diagnosis of HIP was 21 days after ET. The IP ruptured in 46.2% (12/26) of the cases, all of which were treated with surgery. Furthermore, 53.8% (14/26) of the patients in these cases did not experience IP rupture, of which 78.6% (11/14) were treated with ultrasound-guided local drug injection. Regarding the drugs used for local injection, potassium chloride (KCl) was used in four cases, MTX was used in three cases, KCl and MTX were used in one case, MTX and dactinomycin were used in one case, and hypertonic glucose was used in two cases. In addition, two patients with an unruptured interstitial gestational sac underwent laparotomy, and one patient with an unruptured interstitial gestational sac underwent laparoscopic surgery.
In total, 76.9% (20/26) of the reported IUPs had a good outcome, including 10 cases of surgical treatment and 10 cases of ultrasound-guided local drug injection. All newborns were healthy. On the contrary, the poor outcomes of IUP included one fetus with trisomy 21, which resulted in the spontaneous abortion of the IUP. Moreover, patients in three cases had been diagnosed with IUP discontinuation before receiving treatment, and two patients had a postoperative IUP abortion.

5. Discussion

High-risk factors for heterotopic pregnancy (HP) include a history of unilateral or bilateral salpingectomy [11,13,16,18,23,24,28,29,30], EP [11,16,18,24,28,29], ovulation induction, and IVF-ET [8,9,10,11,12,13,14,15,16,18,20,21,22,23,24,25,26,27,28,29,30,31,32]. Particularly, IVF-ET increases the occurrence of IP [33]. EP mostly occurs after fresh embryo transfer and multiple embryo transfer, while the incidence of EP after cleavage-stage transfer and blastocyst-stage transfer is basically similar [34]. Therefore, frozen single blastocyst transfer is now advocated [32].
The diagnosis of HIP mainly relies on ultrasonography, especially TVUS [35]. It has been reported that the sensitivity and specificity of TVUS for HP are 92.4% and 100%, respectively, and the positive and negative predictive values are 100% and 99.9%, respectively [36]. Ultrasonographic criteria for diagnosing an EP mass as an IP are as follows: (1) an eccentric gestational sac (at least 1 cm from the outermost point of the endometrium); (2) the thinning (<5 mm) of the surrounding superficial myometrium; (3) the interstitial line sign, which represents the interstitial part of the tube or the endometrial tube extending from the corner to the middle of the interstitial mass [37]. Our case was diagnosed as an IP based on the sonographic appearance of an ectopic gestational sac that was not connected to the endometrium and was surrounded by a thin interrupted myometrium. In fact, post-embryo transfer luteinizing cysts and ovarian hyperstimulation often lead to atypical ultrasound images. Therefore, medical staff should be highly vigilant for indirect ultrasound signs such as adnexal mass and pelvic effusion. If ultrasound cannot identify the location of the EP, MRI may be a further option. However, due to the presence of IUP, serum β-hCG levels have a limited role in diagnosing HP.
The treatment of HIP aims to terminate IPs, maintain IUPs, and achieve good pregnancy outcomes. In this study, the survival rate of early intervention with IUP was found to reach 76.9%, which is basically consistent with the value of 83.3% reported in the literature [38]. Commonly used clinical treatment methods include surgery, ultrasound interventional therapy, and expectant therapy. Surgery is the main treatment option for ruptured EP [37]. Keratostomy and corneal wedge resection are now more commonly used methods [39]. Surgery can quickly and definitively remove an EP mass, and the IUP live birth rate can reach 80–84% [32]. However, there is also a risk of persistent EP [39] and intrauterine growth retardation [40]. In addition, the operative time tends to be longer, with an average of 55.5 ± 21.3 min, and the average intraoperative blood loss is 76.0 ± 73.2 mL [41]. Surgery also increases the risk of uterine rupture in another pregnancy by about 33% [42]. The effect of surgery on future fertility is controversial. However, recent studies have shown that laparoscopic electrosurgery and mechanical traction do not impair ovarian reserve, and the concentration of anti-Müllerian hormone in the first trimester of re-pregnancy is normal [43]. Asgari et al. [44] followed 194 patients with tubal EP for 18 months and found no significant difference in fertility after MTX, salpingostomy, and salpingectomy. A systematic study showed that salpingectomy for EP had no negative effect on ovarian reserve and ovarian response [45]. From another retrospective study, we also found no difference between the re-pregnancy rates at 3 years of patients undergoing laparoscopic salpingectomy and salpingostomy for their first EP [46]. Surgery also seems to work like medicine without having effects on fertility [47].
Ultrasound interventional therapy refers to ultrasound-guided local drug injection to inactivate the ectopic gestational sac, which is a minimally invasive treatment method that can maximize the integrity of the uterus and reduce the risk of future uterine rupture [8]. The successful delivery rate of IUP after interventional ultrasound can reach 100% [6]. Available drugs are KCl [7,8,14,21] MTX [15,18,29] and hypertonic glucose [20]. Since the first report of the successful treatment of HIP by the ultrasound-guided injection of KCl in 1992 [7], many medical centers have carried out studies, all of which have achieved good results. However, KCL mainly acts on embryo or fetal heart activity, which leads to fetal death, and does not inhibit trophoblast proliferation [48]. As a result, self-limited vaginal bleeding has occasionally been reported during the duration of an IUP [49]. To overcome the inability of KCl to inhibit trophoblast proliferation, Baker et al. [11] combined MTX and KCl to inactivate IP. In 1982, Tanaka et al. [50] reported the intramuscular injection of MTX in the treatment of IP. To the best of our knowledge, this was the first case that maintained tubal patency and protected reproductive function. To date, conservative treatment with multiple doses and/or topical MTX has become the standard of care for IP; however, systemic MTX is contraindicated in the presence of IUP [6,51,52] because high doses of MTX may cause fetal congenital bone deformity or IUP miscarriage [53]. Nevertheless, low-dose MTX treatment has been shown to have no effect on coexisting IUP [29]. The ultrasound-guided local injection of 25 mg MTX has been reported to terminate IPs without affecting IUPs [54,55]. Studies have also proved that MTX doses within the range of 12.5–30 mg will not affect the growth and intelligence of infants [6]. In our case, the patient was diagnosed with IP in the first trimester, and had stable vital signs and no EP rupture. This case was suitable for ultrasound interventional therapy, which can also satisfy the strong willingness of patients to protect IUPs. Therefore, we treated the patient with the local injection of a low dose (20 mg) of MTX under ultrasound guidance. The short-term enlargement of the ectopic mass occurred on the 7th day after the operation, which may have been due to the transient change in the ectopic mass tissue without villous activity as gestation proceeded after interventional treatment. Dynamic ultrasound monitoring revealed that the ectopic mass eventually disappeared. The outcome of this IUP was good. Although the infant had PDA, there have been no reports on the correlation between PDA and MTX. The prognosis of this patient will continue to be monitored, and the health and development of the baby will be followed up with until his childhood to record any unexpected problems that may have been related to MTX exposure in the uterus. This therapy is suitable for patients with stable vital signs, a small gestational age, an unruptured ectopic gestational sac, or contraindications to laparoscopic surgery. Moreover, it is less expensive, and the recovery period is shorter.
In addition, expectant therapy is another possible treatment modality. It is mainly suitable for patients with ectopic gestational sac atrophy, stable vital signs, and close follow-up. Wu et al. [56] reported seven cases of suspected HP with an EP mass less than 4 cm in length, and they achieved good outcomes after expectant treatment. Certainly, there are other reports of IUP miscarriage (1/3) [55]. However, based on the current limited clinical research [57,58,59], the survival rate of IUP with this treatment remains unclear. Thus, it is essential to dynamically evaluate the safety of this therapy when choosing it, and surgical treatment should be applied if necessary.
In short, the diagnosis and treatment of HIP remain challenging. Doctors must establish a complete medical record, carefully inquire about the patient’s past medical history and family history, and repeat inspections for suspicious patients or assisted-pregnancy patients to avoid a missed diagnosis. A systematic examination of the bilateral adnexal uterus cannot be ignored even if the presence of IUP is confirmed. In addition, patient complaints should be noted. Not all patients with HP experience symptoms such as abdominal pain, vaginal bleeding, or tenesmus; back pain [4], gastrointestinal symptoms [38], or pelvic pain [60] may sometimes also be suggestive of HP. Moreover, routine TVUS and regular follow-up after IVF-ET are conducive to the early diagnosis of HP. The treatment of HP must be considered in combination with the patient’s clinical manifestations and needs, and the physician’s experience.

Author Contributions

Writing—original draft preparation, P.L. and X.T.; methodology, R.W. and D.S.; validation and visualization, Q.G.; formal analysis and data curation, Y.C.; investigation, R.Z.; resources, M.X.; supervision, Y.W.; Patient follow-up, H.Z. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by the Shenzhen High-level Hospital Construction Fund (No. GD2019260, YBH2019260), Shenzhen Key Medical Discipline Construction Fund (No. SZXK051, No. SZXK027) and Sanming Project of Medicine in Shenzhen (No. SZSM202111011, No. SZSM202011016).

Institutional Review Board Statement

The study was conducted according to the guidelines of the Declaration of Helsinki, and approved by the Research Ethics Committee of Peking University Shenzhen Hospital (approval code: 2022-011, approval date: 15 February 2022).

Informed Consent Statement

Written informed consent has been obtained from the patient to publish this paper.

Data Availability Statement

Data are available on request from the authors.

Conflicts of Interest

The authors have no conflict of interest to declare.

References

  1. Chen, J.; Huang, D.; Shi, L.; Zhang, S. Prevention, diagnosis, and management of interstitial pregnancy: A review of the literature. Laparosc. Endosc. Robot. Surg. 2019, 2, 12–17. [Google Scholar] [CrossRef]
  2. Chukus, A.; Tirada, N.; Restrepo, R.; Reddy, N.I. Uncommon Implantation Sites of Ectopic Pregnancy: Thinking beyond the Complex Adnexal Mass. Radiographics 2015, 35, 946–959. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. Panelli, D.M.; Phillips, C.H.; Brady, P.C. Incidence, diagnosis and management of tubal and nontubal ectopic pregnancies: A review. Fertil. Res. Pract. 2015, 1, 15. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. Wang, X.; Ma, D.; Zhang, Y.; Chen, Y.; Zhang, Y.; Liu, Z.; Bi, X.; Wu, X.; Fan, J. Rare heterotopic pregnancy after frozen embryo transfer: A case report and literature review. BMC Pregnancy Childbirth 2020, 20, 542. [Google Scholar] [CrossRef]
  5. Basile, F.; Di Cesare, C.; Quagliozzi, L.; Donati, L.; Bracaglia, M.; Caruso, A.; Paradisi, G. Spontaneous heterotopic pregnancy, simultaneous ovarian, and intrauterine: A case report. Case Rep. Obstet. Gynecol. 2012, 2012, 509694. [Google Scholar] [CrossRef] [Green Version]
  6. Yang, X.; Zhu, L.; Le, F.; Wang, Y.; Lou, H.; Gao, H.; Zhu, Y.; Jin, F. The effect of local aspiration and methotrexate injection on live interstitial pregnancy coexisting with live intrauterine pregnancy after assisted reproductive technology. J. Obstet. Gynaecol. Res. 2019, 45, 1296–1302. [Google Scholar] [CrossRef]
  7. Leach, R.E.; Ney, J.A.; Ory, S.J. Selective embryo reduction of an interstitial heterotopic gestation. Fetal Diagn. Ther. 1992, 7, 41–45. [Google Scholar] [CrossRef]
  8. Pérez, J.A.; Sadek, M.M.; Savale, M.; Boyer, P.; Zorn, J.R. Local medical treatment of interstitial pregnancy after in-vitro fertilization and embryo transfer (IVF-ET): Two case reports. Hum. Reprod. 1993, 8, 631–634. [Google Scholar] [CrossRef]
  9. Sherer, D.M.; Scibetta, J.J.; Sanko, S.R. Heterotopic quadruplet gestation with laparoscopic resection of ruptured interstitial pregnancy and subsequent successful outcome of triplets. Am. J. Obstet. Gynecol. 1995, 172 (Pt 1), 216–217. [Google Scholar] [CrossRef]
  10. Luckas, M. Survival of intrauterine twins and an interstitial singleton fetus from heterotopic in vitro fertilization-embryo transfer pregnancy. Br. J. Obstet. Gynecol. 1997, 104, 751–752. [Google Scholar] [CrossRef]
  11. Baker, V.L.; Givens, C.R.; Cadieux, M.C. Transvaginal reduction of an interstitial heterotopic pregnancy with preservation of the intrauterine gestation. Am. J. Obstet. Gynecol. 1997, 176, 1384–1385. [Google Scholar] [CrossRef] [PubMed]
  12. Dumesic, D.A.; Damario, M.A.; Session, D.R. Interstitial heterotopic pregnancy in a woman conceiving by in vitro fertilization after bilateral salpingectomy. Mayo Clin. Proc. 2001, 76, 90–92. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  13. Nikolaou, D.S.; Lav Ery, S.; Rowena Bev, A.N.; Margara, R.; Trew, G. Triplet heterotopic pregnancy with an intrauterine monochorionic diamniotic twin pregnancy and an interstitial pregnancy following in vitro fertilisation and transfer of two embryos. J. Obstet. Gynaecol. 2002, 22, 94–95. [Google Scholar] [CrossRef] [PubMed]
  14. Ghazeeri, G.S.; Phillips, O.P.; Emerson, D.S.; Kutteh, W.H.; Ke, R.W. Live birth after treatment of a heterotopic cornual pregnancy with fetal intrathoracic KCI. A case report. J. Reprod. Med. 2002, 47, 1038–1040. [Google Scholar]
  15. Oyawoye, S.; Chander, B.; Pavlovic, B.; Hunter, J.; Gadir, A.A. Heterotopic pregnancy: Successful management with aspiration of cornual/interstitial gestational sac and instillation of small dose of methotrexate. Fetal Diagn. Ther. 2003, 18, 1–4. [Google Scholar] [CrossRef]
  16. Chang, Y.; Lee, J.N.; Yang, C.H.; Hsu, S.C.; Tsai, E.M. An unexpected quadruplet heterotopic pregnancy after bilateral salpingectomy and replacement of three embryos. Fertil. Steril. 2003, 80, 218–220. [Google Scholar] [CrossRef]
  17. Lialios, G.A.; Kallitsaris, A.; Kabisios, T.; Messinis, I.E. Ruptured heterotopic interstitial pregnancy: Rare case of acute abdomen in a Jehovah’s Witness patient. Fertil. Steril. 2008, 90, 1200.e15–1200.e17. [Google Scholar] [CrossRef]
  18. Fujioka, S.; Yamashita, Y.; Kawabe, S.; Kamegai, H.; Terai, Y.; Ohmichi, M. A case of a methotrexate-resistant ectopic pregnancy in which dactinomycin was effective as a second-line chemotherapy. Fertil. Steril. 2009, 91, 929.e13–929.e15. [Google Scholar] [CrossRef]
  19. Aust, T.; O’Neill, A.; Cario, G. Purse-string suture technique to enable laparoscopic management of the interstitial gestation of a heterotopic pregnancy. Fertil. Steril. 2011, 95, 261–263. [Google Scholar] [CrossRef]
  20. Wang, Y.; Ma, C.H.; Qiao, J.; Chen, X.N.; Liu, P. Efficacy of local aspiration in the conservative treatment of live interstitial pregnancy coexisting with live intrauterine pregnancy after in vitro fertilization and embryo transfer. Chin. Med. J. 2012, 125, 1345–1348. [Google Scholar]
  21. Savelli, L.; Fabbri, F.; Di Donato, N.; De Meis, L. Heterotopic interstitial pregnancy successfully treated with ultrasound-guided potassium chloride injection in the ectopic embryo. J. Obstet. Gynaecol. 2014, 34, 276–277. [Google Scholar] [CrossRef] [PubMed]
  22. Xu, Y.; Lu, Y.; Chen, H.; Li, D.; Zhang, J.; Zheng, L. Heterotopic Pregnancy After InVitro Fertilization and Embryo Transfer After Bilateral Total Salpingectomy/Tubal Ligation: Case Report and Literature Review. J. Minim. Invasive Gynecol. 2016, 23, 338–345. [Google Scholar] [CrossRef] [PubMed]
  23. Paradise, C.; Carlan, S.J.; Holloman, C. Spontaneous uterine cornual rupture at 26 weeks’ gestation in an interstitial heterotopic pregnancy following in vitro fertilization. J. Clin. Ultrasound 2016, 44, 322–325. [Google Scholar] [CrossRef] [PubMed]
  24. Aoki, Y.; Kumakiri, J.; Itakura, A.; Kikuchi, I.; Takahashi, N.; Satoru, T. Should sexual intercourse be avoided during the embryo transfer cycle? Life-threatening ruptured heterotopic pregnancy after single thawed embryo transfer: Case report and review of the literature. Clin. Exp. Obstet. Gynecol. 2017, 44, 489–491. [Google Scholar] [CrossRef]
  25. Dendas, W.; Schobbens, J.C.; Mestdagh, G.; Meylaerts, L.; Verswijvel, G.; Van Holsbeke, C. Management and outcome of heterotopic interstitial pregnancy: Case report and review of literature. Ultrasound 2017, 25, 134–142. [Google Scholar] [CrossRef]
  26. Chen, T.S.; Wu, M.H. Heterotopic pregnancy after in vitro fertilization in a patient with distal tubal hypoplasia. Gynecol. Minim. Invasive Ther. 2017, 6, 217–218. [Google Scholar] [CrossRef]
  27. Anderson, J.; Patterson, C.; Riley, A. Heterotopic interstitial pregnancy: A case report. Case Rep. Womens Health 2018, 17, 8–10. [Google Scholar] [CrossRef]
  28. Siristatidis, C.; Bellos, I.; Karageorgiou, V.; Kapnias, D. A three-layer reconstruction of the uterus in a heterotopic interstitial pregnancy. J. Obstet. Gynaecol. 2019, 39, 564–565. [Google Scholar] [CrossRef]
  29. Lee, K.N.; Ham, H.J.; Whang, E.J.; Eun-Ji, J.; Seung-Hye, C.; Lee, K.Y. Successful heterotopic pregnancy with prior radical trachelectomy after transabdominal cervico isthimic cerclage with methotrexate treatment. J. Obstet. Gynaecol. Res. 2020, 46, 663–667. [Google Scholar] [CrossRef]
  30. Wang, Q.; Pan, X.L.; Qi, X.R. Post-salpingectomy interstitial heterotopic pregnancy after in vitro fertilization and embryo transfer: A case report. World J. Clin. Cases 2021, 9, 6950–6955. [Google Scholar] [CrossRef]
  31. Talbot, K.; Simpson, R.; Price, N.; Jackson, S.R. Heterotopic pregnancy. J. Obstet. Gynaecol. 2011, 31, 7–12. [Google Scholar] [CrossRef] [PubMed]
  32. Jeon, J.H.; Hwang, Y.I.; Shin, I.H.; Park, C.W.; Yang, K.M.; Kim, H.O. The Risk Factors and Pregnancy Outcomes of 48 Cases of Heterotopic Pregnancy from a Single Center. J. Korean Med. Sci. 2016, 31, 1094–1099. [Google Scholar] [CrossRef]
  33. Xiao, S.; Mo, M.; Hu, X.; Zhang, H.; Yong, Z. Study on the incidence and influences on heterotopic pregnancy from embryo transfer of fresh cycles and frozen-thawed cycles. J. Assist. Reprod. Genet. 2018, 35, 677–681. [Google Scholar] [CrossRef] [PubMed]
  34. Muller, V.; Makhmadalieva, M.; Kogan, I.; Fedorova, I.; Lesik, E.; Komarova, E.; Dzhemlikhanova, L.; Niauri, D.; Gzgzyan, A.; Ailamazyan, E. Ectopic pregnancy following in vitro fertilization: Meta-analysis and single-center experience during 6 years. Gynecol. Endocrinol. 2016, 32 (Suppl. S2), 69–74. [Google Scholar] [CrossRef] [Green Version]
  35. Carusi, D. Pregnancy of unknown location: Evaluation and management. Semin Perinatol. 2019, 43, 95–100. [Google Scholar] [CrossRef]
  36. Li, X.H.; Ouyang, Y.; Lu, G.X. Value of transvaginal sonography in diagnosing heterotopic pregnancy after in-vitro fertilization with embryo transfer. Ultrasound Obstet. Gynecol. 2013, 41, 563–569. [Google Scholar] [CrossRef] [PubMed]
  37. Po, L.; Thomas, J.; Mills, K.; Zakhari, A.; Tulandi, T.; Shuman, M.; Page, A. Guideline No. 414: Management of Pregnancy of Unknown Location and Tubal and Nontubal Ectopic Pregnancies. J. Obstet. Gynaecol. Can. 2021, 43, 614–630.e1. [Google Scholar] [CrossRef] [PubMed]
  38. Ch, L.; Wang, H.; Xu, D.; Chen, L.Q.; He, J. Management and pregnancy outcomes of heterotopic pregnancy. Chin. J. Obstet. Gynecol. 2018, 53, 768–775. [Google Scholar]
  39. Khan, Z.; Lindheim, S.R. In pursuit of understanding interstitial pregnancies: A rare yet high-risk ectopic pregnancy. Fertil. Steril. 2019, 112, 246–247. [Google Scholar] [CrossRef] [Green Version]
  40. Vilos, G.A. Laparoscopic resection of a heterotopic cornual pregnancyfollowed by term vaginal delivery. J. Am. Assoc. Gynecol. Laparosc. 1995, 2, 471–473. [Google Scholar] [CrossRef]
  41. Kwon, B.; Kang, S.; Lee, H.J.; Kim, M.; Lee, Y.H.; Im, J.; Moon, M.J.; Ahn, E.H.; Kim, Y.R. Non-surgical management and obstetric outcomes of heterotopic interstitial pregnancies. Minim. Invasive Ther. Allied Technol. 2020, 29, 375–379. [Google Scholar] [CrossRef]
  42. Hua, Z.; Wu, M. Spontaneous rupture of the uterus following salpingectomy: A case report and literature review. J. Int. Med. Res. 2019, 47, 5328–5336. [Google Scholar] [CrossRef] [PubMed]
  43. Rodgers, R.; Carter, J.; Reid, G.; Krishnan, S.; Ludlow, J.; Cooper, M.; Abbott, J. The effect of laparoscopic salpingectomy for ectopic pregnancy on ovarian reserve. Aust. N. Z. J. Obstet. Gynaecol. 2020, 60, 278–283. [Google Scholar] [CrossRef] [PubMed]
  44. Asgari, Z.; Chegini, V.; Hosseini, R.; Mohajeri, M.; Ansari, I. Fertility outcomes subsequent to medical and surgical treatment for ectopic pregnancy: A retrospective cohort study in Iran. Int. J. Reprod. Biomed. 2021, 19, 881–888. [Google Scholar] [CrossRef] [PubMed]
  45. Luo, J.; Shi, Y.; Liu, D.; Yang, D.; Xia, X. The effect of salpingectomy on the ovarian reserve and ovarian response in ectopic pregnancy: A systematic review and meta-analysis. Medicine 2019, 98, e17901. [Google Scholar] [CrossRef]
  46. Chen, L.; Zhu, D.; Wu, Q.; Yu, Y. Fertility outcomes after sapingectomy or salpingotomy for tubal ectopic pregnancy, a retrospective study in China. Int. J. Surg. 2017, 48, 59–63. [Google Scholar] [CrossRef]
  47. Yousefnezhad, A.; Pirdehghan, A.; Roshandel Rad, M.; Eskandari, A.; Ahmadi, S. Comparison of the pregnancy outcomes between the medical and surgical treatments in tubal ectopi pregnancy. Int. J. Reprod. Biomed. 2018, 16, 31–34. [Google Scholar] [CrossRef] [Green Version]
  48. Leziak, M.; Żak, K.; Frankowska, K.; Ziółkiewicz, A.; Perczyńska, W.; Abramiuk, M.; Tarkowski, R.; Kułak, K. Future Perspectives of Ectopic Pregnancy Treatment-Review of Possible Pharmacological Methods. Int. J. Environ. Res. Public Health 2022, 19, 14230. [Google Scholar] [CrossRef]
  49. Gyamfi, C.; Cohen, S.; Stone, J.L. Maternal complication of cervical heterotopic pregnancy after successful potassium chloride fetal reduction. Fertil. Steril. 2004, 82, 940–943. [Google Scholar] [CrossRef]
  50. Tanaka, T.; Hayashi, H.; Kutsuzawa, T.; Fujimoto, S.; Ichinoe, K. Treatment of interstitial ectopic pregnancy with methotrexate: Report of a successful case. Fertil. Steril. 1982, 37, 851–852. [Google Scholar] [CrossRef]
  51. Hiersch, L.; Krissi, H.; Ashwal, E.; From, A.; Wiznitzer, A.; Peled, Y. Effectiveness of medical treatment with methotrexate for interstitial pregnancy. Aust. N. Z. J. Obstet. Gynaecol. 2014, 54, 576–580. [Google Scholar] [CrossRef]
  52. Benifla, J.L.; Fernandez, H.; Sebban, E.; Darai, E.; Frydman, R.; Madelenat, P. Alternative to surgery of treatment of unruptured interstitial pregnancy: 15 cases of medical treatment. Eur. J. Obstet. Gynecol. Reprod. Biol. 1996, 70, 151–156. [Google Scholar] [CrossRef]
  53. Lei, R.; Liang, J.; Ling, X.; Xu, J.; Liang, S.; Zhou, H.; Zhang, B. Use of Laparoscopic Slip Knot with Purse-String Suture in Surgical Management of Unruptured Heterotopic Interstitial Pregnancies. Med. Sci. Monit. 2020, 26, e921185. [Google Scholar] [CrossRef] [PubMed]
  54. Ferreira, I.; Ramalho, I.; Marques, J.P.; Carvalho, M.J.; Guas, F. Live birth after treatment of a spontaneous ovarian heterotopic pregnancy: A case report. Case Rep. Women’s Health 2019, 24, e00144. [Google Scholar]
  55. Framarino-dei-Malatesta, M.; Piccioni, M.G.; Derme, M.; Polidori, N.F.; Tibaldi, V.; Iannini, I.; Masselli, G. Transabdominal ultrasound-guided injection of methotrexate in the treatment of ectopic interstitial pregnancies. J. Clin. Ultrasound 2014, 42, 522–526. [Google Scholar] [CrossRef]
  56. Wu, Z.; Zhang, X.; Xu, P.; Huang, X. Clinical analysis of 50 patients with heterotopic pregnancy after ovulation induction or embryo transfer. Eur. J. Med. Res. 2018, 23, 17. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  57. Fernandez, H.; Lelaidier, C.; Doumerc, S.; Fournet, P.; Olivennes, F.; Frydman, R. Nonsurgical treatment of heterotopic pregnancy: A report of six cases. Fertil. Steril. 1993, 60, 428–432. [Google Scholar] [CrossRef]
  58. Baxi, A.; Kaushal, M.; Karmalkar, H.; Sahu, P.; Kadhi, P.; Daval, B. Successful expectant management of tubal heterotopic pregnancy. J. Hum. Reprod. Sci. 2010, 3, 108–110. [Google Scholar]
  59. Sentilhes, L.; Bouet, P.E.; Gromez, A.; Poilblanc, M.; Lefebvre-Lacoeuille, C.; Descamps, P. Successful expectant management for a cornual heterotopic pregnancy. Fertil. Steril. 2009, 91, 934.e11–934.e13. [Google Scholar] [CrossRef]
  60. Thakur, U.; Atmuri, K.; Borozdina, A. Acute pelvic pain following miscarriage heterotopic pregnancy must be excluded: Case report. BMC Emerg. Med. 2019, 19, 59. [Google Scholar] [CrossRef]
Jpm 13 00332 g001 550
Figure 1. Ultrasound images on the 38th day after ET. (A) A two-dimensional ultrasound image: (a) the interstitial gestational sac in the interstitium of the right fallopian tube and (b) the intrauterine gestational sac. (B) A color Doppler ultrasound image showing an abundant blood flow signal around the IP.
Figure 1. Ultrasound images on the 38th day after ET. (A) A two-dimensional ultrasound image: (a) the interstitial gestational sac in the interstitium of the right fallopian tube and (b) the intrauterine gestational sac. (B) A color Doppler ultrasound image showing an abundant blood flow signal around the IP.
Jpm 13 00332 g001
Jpm 13 00332 g002 550
Figure 2. Ultrasound images on the 14th day after the injection of MTX. (A) A two-dimensional ultrasound image, which reveals the growth of the ectopic gestational sac. (B) A color Doppler ultrasound image showing an abundant blood flow signal around the IP.
Figure 2. Ultrasound images on the 14th day after the injection of MTX. (A) A two-dimensional ultrasound image, which reveals the growth of the ectopic gestational sac. (B) A color Doppler ultrasound image showing an abundant blood flow signal around the IP.
Jpm 13 00332 g002
Jpm 13 00332 g003 550
Figure 3. (A) The change in the size of the interstitial gestational sac. (B) The change in the serum β-hCG level. The day of injection was set as day 0. Mass size = long diameter short diameter2/2.
Figure 3. (A) The change in the size of the interstitial gestational sac. (B) The change in the serum β-hCG level. The day of injection was set as day 0. Mass size = long diameter short diameter2/2.
Jpm 13 00332 g003
Table
Table 1. Summary and characteristics of relevant literatures and cases.
Table 1. Summary and characteristics of relevant literatures and cases.
ReferenceAge (Years)Medical HistoryManner of Fertilization (Embryo Type and Number if ET)SymptomsSite of TPTime of Admission *EP Rupture (Yes or NO) + InterventionIP OutcomeIUP Outcome + Neonatal Malformation (Yes or No)
Leach et al., 1992 [7]29Bilateral isthmic-isthmic tubal anastomosisIntrauterine inseminationPP + VBIUP + right IP8 weeksNo + KCLInactivatedCS + No
Pérez et al., 1993 [8]35Secondary tubal infertilityIVF-ET (fresh 4)-IUP + left IP33 days after ETNo + KCLInactivatedFC + No
Sherer et al., 1995 [9]32-IVF-ET (6)ABPIUP + IP8 weeksYes + LSInactivatedCS/33 weeks + No
Luckas et al., 1997 [10]24Secondary infertility due to severe tubal damageIVF-ET (fresh 3)ABP + UTIUP + right IP8 weeksYes + LTCS/30 weeks+ newborn healthCS/30 weeks + No
Baker et al., 1997 [11]34Left ST + EPIVF-ET (fresh 4)-IUP + IP34 days after ETNo + KCL and MTX InactivatedFC + No
Dumesic et al., 2001 [12]37BHIVF-ET (4)ABPIUP + IP4 weeksYes + LS + LTInactivatedSA
Nikolaou et al., 2002 [13]31Left oophorectomy + partial STIVF-ET (fresh 2)Intermittent discomfort in the left iliac fossaIUP + left IP8 weeksYes + LTInactivatedND/33 weeks + No
Ghazeeri et al., 2002 [14]29EndometriosisIVF-ET (3)-IUP + right IP28 days after ETNo + KCL InactivatedND/36 weeks + No
Oyawoye et al., 2003 [15]29PIIVF-ET (3)-IUP + left IP6 weeks + 3 daysNo + MTXInactivatedND/39 weeks + No
Chang et al., 2003 [16]21Bilateral ST + EPIVF-ET (fresh 3)VBIUP + left IP35 days after ETNo + LTInactivatedCS/38 weeks + No
Lialios et al., 2008 [17] 29-SCABPIUP + right IP6 weeks + 5 daysYes + LSInactivatedCS/37 weeks + No
Fujioka et al., 2008 [18]39Left ST + EPIVF-ET (frozen 2)VBIntrauterine blighted ovum pregnancy + right IP28 days after ETNo + MTX IM, 3 times, 50 mg/m2 each time + dactinomycin 12 mg/kgInactivatedSA
Thomas et al., 2011 [19]---PP + VBIUP + right IP6 weeksNo + LSInactivatedSA
Wang et al., 2012 [20]29PIIVF-ET (frozen 3)-IUP + right IP21 days after ETNo + IP aspiration and hypertonic glucose infusion guided by ultrasound guidanceInactivatedCS/35 weeks + No
Wang et al., 2012 [20]27PIIVF-ET (fresh 2)-IUP + right IP30 days after ETNo + IP aspiration and hypertonic glucose infusion guided by ultrasound guidanceInactivatedND/37 weeks + No
Savelli et al., 2014 [21]27-IVF-ET (2)-IUP + right IP6 weeks + 5 daysNo + KCL InactivatedCS/35 weeks + No
Xu et al., 2015 [22]28PI + bilateral tubal ligationIVF-ET (fresh 2)ABPIUP + left IP48 days after ETYes + LTInactivatedSA
Paradise et al., 2016 [23]38FTSIVF-ET (-)ABP IUP + IP26 weeks +Yes + LTCS/26 weeks+ newborn healthCS/26 weeks + No
Aoki et al., 2016 [24]33Left ST+ EPIVF-ET (frozen 1)ABP IUP + IP28 days after ETYes + LSInactivatedCS/38 weeks + No
Dendas et al., 2017 [25]35Right accessory resection + laparoscopic oophoroplasty and adhesion lysisIVF-ET (frozen 2)Intermittent colicky pain in the right iliac fossa with nausea and constipationIUP + IP16 weeksYes + LS + LTInactivatedCS/33 weeks + No
Chen et al., 2017 [26]27Bilateral tubal obstruction with hydrosalpinxIVF-ET (frozen 3)ABP +VBIUP + right IP31 days after ETYes + LSInactivatedND/39 weeks + No
Anderson et al., 2018 [27]27--ABP IUP + left IP9 weeksYes + LTInactivatedSA
Siristatidis et al., 2018 [28]35FTS + EP hydrosalpinxIVF-ET (frozen)ABP Intrauterine withered egg pregnancy + right IP8 weeks + 3 daysNo + LTInactivatedSA
Lee et al., 2020 [29]34Cervical cancer + Left FTS + EP IVF-ET (-)-IUP + left IP8 weeksNo + transabdominal cerclage+ MTX InactivatedCS/38 weeks + No
Wang et al., 2021 [30]29FTSIVF-ET (frozen 2)ABP IUP + left IP5 weeksYes + LSInactivatedCS/39 weeks + No
Present case31PIIVF-ET (frozen 2)VBIUP + Right IP8 weeksYes + MTXInactivatedND/39 weeks + PDA
Notes: ET = embryo transfer, LS = laparoscopy, LT = laparotomy, ABP = abdominal pain, VB = vaginal bleeding, PP = pelvic pain, UT = uterine tenderness, KCL = KCL injection guided by ultrasound guidance, MTX = MTX injection guided by ultrasound guidance, cause for salpingectomy bilateral ectopic pregnancies, BH = bilateral hydrosalpinx, FTS = fallopian tube resection, ST = bilateral salpingectomy, PI = primary infertility, CS = cesarean section, FC = full-term childbirth, SA = spontaneous abortion, SC = spontaneous conception, ND = natural delivery. * Refers to the time after embryo transfer.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Li, P.; Tan, X.; Chen, Y.; Ge, Q.; Zhou, H.; Zhang, R.; Wang, Y.; Xue, M.; Wu, R.; Sun, D. Successful Ultrasound-Guided Methotrexate Intervention in the Treatment of Heterotopic Interstitial Pregnancy: A Case Report and Literature Review. J. Pers. Med. 2023, 13, 332. https://doi.org/10.3390/jpm13020332

AMA Style

Li P, Tan X, Chen Y, Ge Q, Zhou H, Zhang R, Wang Y, Xue M, Wu R, Sun D. Successful Ultrasound-Guided Methotrexate Intervention in the Treatment of Heterotopic Interstitial Pregnancy: A Case Report and Literature Review. Journal of Personalized Medicine. 2023; 13(2):332. https://doi.org/10.3390/jpm13020332

Chicago/Turabian Style

Li, Ping, Xiao Tan, Yi Chen, Qiaoli Ge, Haiying Zhou, Renrong Zhang, Yue Wang, Min Xue, Ruifang Wu, and Desheng Sun. 2023. "Successful Ultrasound-Guided Methotrexate Intervention in the Treatment of Heterotopic Interstitial Pregnancy: A Case Report and Literature Review" Journal of Personalized Medicine 13, no. 2: 332. https://doi.org/10.3390/jpm13020332

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop